Wheat Belly: Lose the Wheat, Lose the Weight and Find Your Path Back to Health (38 page)

26
. Gerstein HC, Swedberg K, Carlsson J et al. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Arch Intern Med 2008 Aug 11;168(15):1699-704.

27
. Khaw et al.
Brit Med J
2001 Jan 6;322(7277):15-8.

28
. Swami-Mruthinti S, Shaw SM, Zhao HR et al. Evidence of a glycemic threshold for the development of cataracts in diabetic rats.
Curr Eye Res
1999 Jun;18(6):423-9.

29
. Rowe NG, Mitchell PG, Cumming RG, Wans JJ. Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study.
Opththalmic Epidemiol
2000 Jun;7(2):103-14.

30
. Sperduto RD, Seigel D. Senile lens and senile macular changes in a population-based sample.
Am J Opththalmol
1980 Jul;90(1):86-91.

31
. Stitt et al.
Mol Med
1997;3:617-27.

32
. Ishibashi T, Kawaguchi M, Sugimoto K et al. Advanced glycation end product-mediated matrix metalloproteinase-9 and apoptosis via renin-angiotensin system in type 2 diabetes.
JAtheroscler Thromb
2010; 17(6):578-89.

33
. Vlassara H, Torreggiani M, Post JB et al. Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging.
Kidney Int Suppl
2009 Dec;(114):S3-11.

CHAPTER 10

1
. Stalenhoef AF, de Graaf J. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL.
Curr Opin Lipidol
2008;19:355-61.

2
. Lamarche B, Lemieux I, Després JP. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
Diabetes Metab
1999 Sep;25(3):199-211.

3
. Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein.
Biochem Soc Trans
2003;31:1066-9.

4
. De Graaf J, Hak-Lemmers HL, Hectors MP et al. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.
Arterioscler Thromb
1991 Mar-Apr;11(2):298-306.

5
. Younis N, Sharma R, Soran H et al. Glycation as an atherogenic modification of LDL.
Curr Opin Lipidol
2008 Aug;19(4):378-84.

6
. Zambon A, Hokanson JE, Brown BG, Brunzell JD. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.
Circulation
1999 Apr 20;99(15):1959-64.

7
. Ginsberg HN. New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism.
Circulation
2002;106:2137-42.

8
. Stalenhoef et al.
Curr Opin Lipidol
2008;19:355-61.

9
. Ford ES, Li C, Zhgao G et al. Hypertriglyceridemia and its pharmacologic treatment among US adults.
Arch Intern Med
2009 Mar 23;169(6):572-8.

10
. Superko HR. Beyond LDL cholesterol reduction.
Circulation
1996 Nov 15;94(10):2351-4.

11
. Lemieux I, Couillard C, Pascot A et al.) The small, dense LDL phenotype as a correlate of postprandial lipemia in men.
Atherosclerosis
2000;153:423-32.

12
. Nordestgaard BG, Benn M, Schnohr P et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
JAMA
2007 Jul 18;298(3):299-308.

13
. Sniderman AD. How, when, and why to use apolipoprotein B in clinical practice.
Am J Cardiol
2002 Oct 17;90(8A):48i-54i.

14
. Otvos JD, Jeverajah EJ, Cromwell WC. Measurement issues related to lipoprotein heterogeneity.
Am J Cardiol
2002 Oct 17;90(8A):22i-9i.

15
. Parks EJ, Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: Hisotrical perspective and review of biological mechanisms.
Am J Clin Nutr
2000; 71:412-23.

16
. Hudgins LC. Effect of high-carbohydrate feeding on triglyceride and saturated fatty acid synthesis.
Proc Soc Exp Biol Med
2000;225:178-83.

17
. Savage DB, Semple RK. Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance.
Curr Opin Lipidol
2010 Aug;21(4):329-36.

18
. Therond P. Catabolism of lipoproteins and metabolic syndrome.
Cur Opin Clin Nutr Metab Care
2009;12:366-71.

19
. Centers for Disease Control 2010, Dietary intake for adults 20 years of age and over, at
http://www.cdc.gov/nchs/fastats/diet.htm
.

20
. Capeau J. Insulin resistance and steatosis in humans.
Diabetes Metab
2008;34:649-57.

21
. Adiels M, Olofsson S, Taskinen R, Borén J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
Arteroscler Thromb Vasc Biol
2008;28:1225-36.

22
. Westman EC, Yancy WS Jr, Mavropoulos JC et al. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus.
Nutr Metab (Lond)
2008 Dec 19;5:36.

23
. Temelkova-Kurktschiev T, Hanefeld M. The lipid triad in type 2 diabetes—prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
Exp Clin Endocrinol Diabetes
2004 Feb;112(2):75-9.

24
. Krauss RM. Atherogenic lipoprotein phenotype and diet-gene interactions.
J Nutr
2001 Feb;131(2):340S-3S.

25
. Wood RJ, Volek JS, Liu Y et al. Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men.
J Nutr
2006;136:384-9.

CHAPTER 11

1
. Hadjivassiliou M, Sanders DS, Grünewald RA et al. Gluten sensitivity: from gut to brain.
Lancet
2010 March;9:318-30.

2
. Holmes GK. Neurological and psychiatric complications in coeliac disease. In Gobbi G, Anderman F, Naccarato S et al., editors:
Epilepsy and other neurological disorders in coeliac disease.
London: John Libbey; 1997:251-64.

3
. Hadjivassiliou M, Grünewald RA, Sharrack B et al. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics.
Brain
2003;126:685-91.

4
. Cooke W, Smith W. Neurological disorders associated with adult coeliac disease.
Brain
1966;89:683-722.

5
. Hadjivassiliou M, Boscolo S, Davies-Jones GA et al. The humoral response in the pathogenesis of gluten ataxia.
Neurology
2002 Apr 23;58(8):1221-6.

6
. Bürk K Bosch S, Müller CA et al. Sporadic cerebellar ataxia associated with gluten sensitivity.
Brain
2001;124:1013-9.

7
. Wilkinson ID, Hadjivassiliou M, Dickson JM et al. Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia.
J Neurol Neurosurg Psychiatry
2005;76:1011-3.

8
. Hadjivassiliou M, Davies-Jones G, Sanders DS, Grünewald RA. Dietary treatment of gluten ataxia.
J Neurol Neurosurg Psychiatry
2003;74:1221-4.

9
. Hadjivassiliou et al.
Brain
2003;126:685-91.

10
. Ibid.

11
. Hadjivassiliou M, Kandler RH, Chattopadhyay AK et al. Dietary treatment of gluten neuropathy.
Muscle Nerve
2006 Dec;34(6):762-6.

12
. Bushara KO. Neurologic presentation of celiac disease.
Gastroenterol
2005;128:S92-7.

13
. Hadjivassiliou et al.
Lancet
2010 March;9:318-30.

14
. Hu WT, Murray JA, Greenway MC et al. Cognitive impairment and celiac disease.
Arch Neurol
2006;63:1440-6.

15
. Ibid.

16
. Hadjivassiliou et al.
Lancet
2010 March;9:318-30.

17
. Peltola M, Kaukinen K, Dastidar P et al. Hippocampal sclerosis in refractory temporal lobe epilepsy is associated with gluten sensitivity.
J Neurol Neurosurg
Psychiatry 2009 Jun;80(6):626-30.

18
. Cronin CC, Jackson LM, Feighery C et al. Coeliac disease and epilepsy.
QJM
1998;91:303-8.

19
. Chapman RW, Laidlow JM, Colin-Jones D et al. Increased prevalence of epilepsy in celiac disease.
Brit Med J
1978;2:250-1.

20
. Mavroudi A, Karatza E, Papastravrou T et al. Successful treatment of epilepsy and celiac disease with a gluten-free diet.
Pediatr Neurol
2005;33:292-5.

21
. Harper E, Moses H, Lagrange A. Occult celiac disease presenting as epilepsy and MRI changes that responded to gluten-free diet.
Neurology
2007;68:533.

22
. Ranua J, Luoma K, Auvinen A et al. Celiac disease-related antibodies in an epilepsy cohort and matched reference population.
Epilepsy Behav
2005 May;6(3):388-92.

CHAPTER 12

1
. Smith RN, Mann NJ, Braue A et al. A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial.
Am J Clin Nutr
2007 Jul;86(1):107-15.

2
. Cordain L, Lindeberg S, Hurtado Metal. Acne vulgaris: A disease of Western civilization.
Arch Dermatol
2002 Dec;138:1584-90.

3
. Miyagi S, Iwama N, Kawabata T, Hasegawa K. Longevity and diet in Okinawa, Japan: the past, present and future.
Asia Pac J Public Health
2003;15 Suppl:S3-9.

4
. Cordain.
Arch Dermatol
2002 Dec;138:1584-90.

5
. Bendiner E. Disastrous trade-off: Eskimo health for white civilization.
Hosp Pract
1974;9:156-89.

6
. Steiner PE. Necropsies on Okinawans: anatomic and pathologic observations.
Arch Pathol
1946;42:359-80.

7
. Schaefer O. When the Eskimo comes to town.
Nutr Today
1971;6:8-16.

8
. Fulton JE, Plewig G, Kligman AM. Effect of chocolate on acne vulgaris.
JAMA
1969 Dec 15;210(11):2071-4.

9
. Rudman SM, Philpott MP, Thomas G, Kealey T. The role of IGF-I in human skin and its appendages: morphogen as well as mitogen?
J Invest Dermatol
1997 Dec;109(6):770-7.

10
. Cordain.
Arch Dermatol
2002 Dec;138:1584-90.

11
. Franks S. Polycystic ovary syndrome.
N Engl J Med
2003;13:853-61.

12
. Tan S, Hahn S, Benson S et al. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
Eur J Endocrinol
2007 Nov;157(5):669-76.

13
. Cordain L. Implications for the role of diet in acne.
Semin Cutan Med Surg
2005 Jun;24(2):84-91.

14
. Frid H, Nilsson M, Holst JJ, Björck IM. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects.
Am J Clin Nutr
2005 Jul;82(1):69-75.

15
. Adebamowo CA, Spiegelman D, Danby FW et al. High school dietary dairy intake and teenage acne.
J Am Acad Dermatol
2005 Feb;52(2):207-14.

16
. Abulnaja KO. Changes in the hormone and lipid profile of obese adolescent Saudi females with acne vulgaris.
Braz J Med Biol Res
2009 Jun;42(6):501-5.

17
. Smith RN, Mann NJ, Braue A et al. A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial.
Am J Clin Nutr
2007 Jul;86(1):107-15.

18
. Abenavoli L, Leggio L, Ferrulli A et al. Cutaneous manifestations in celiac disease.
World J Gastrolenterol
2006 Feb 16;12(6):843-52.

19
. Junkins-Hopkins J. Dermatitis herpetiformis: Pearls and pitfalls in diagnosis and management.
J Am Acad Dermatol
2001;63:526-8.

20
. Abenavoli et al.
World J Gastrolenterol
2006 Feb 16;12(6):843-52.

21
. Kong AS, Williams RL, Rhyne R et al. Acanthosis nigricans: high prevalence and association with diabetes in a practice-based research network consortium—a PRImary care Multi-Ethnic network (PRIME Net) study.
J Am Board Fam Med
2010 Jul-Aug;23(4):476-85.

22
. Corazza GR, Andreani ML, Venturo N et al. Celiac disease and alopecia areata: report of a new association.
Gastroenterol
1995 Oct;109(4):1333-7.

23
. Gregoriou S, Papafragkaki D, Kontochristopoulos G et a. Cytokines and other mediators in alopecia areata.
Mediators Inflamm
2010;928030.

CHAPTER 13

1
. Trepanowski JF, Bloomer RJ. The impact of religious fasting on human health.
Nutr J
2010 Nov 22;9:57.

2
. Kendall CW, Josse AR, Esfahani A, Jenkins DJ. Nuts, metabolic syndrome and diabetes.
Br J Nutr
2010 Aug;104(4):465-73.

3
. Astrup A, Dyerberg J, Elwood P et al. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?
Am J Clin Nutr
2011 Apr;93(4):684-8.

4
. Ostman EM, Liljeberg Elmstähl HG, Björck IM. Inconsistency between glycemic and insulinemic responses to regular and fermented milk products.
Am J Clin Nutr
2001 Jul;74(1):96-100.

EPILOGUE

1
. Diamond J. The worst mistake in the history of the human race.
Discover
1987 May;64-6.